These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 99243)

  • 1. Deoxyguanosine toxicity in a mouse T lymphoma: relationship to purine nucleoside phosphorylase-associated immune dysfunction.
    Gudas LJ; Ullman B; Cohen A; Martin DW
    Cell; 1978 Jul; 14(3):531-8. PubMed ID: 99243
    [No Abstract]   [Full Text] [Related]  

  • 2. Mechanisms of 2'-deoxyguanosine toxicity in mouse T-lymphoma cells with purine nucleoside phosphorylase deficiency and resistance to inhibition of ribonucleotide reductase by dGTP.
    Duan DS; Nagashima T; Hoshino T; Waldman F; Pawlak K; Sadee W
    Biochem J; 1990 Jun; 268(3):725-31. PubMed ID: 2114100
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isolation and characterization of purine-nucleoside phosphorylase-deficient T-lymphoma cells and secondary mutants with altered ribonucleotide reductase: genetic model for immunodeficiency disease.
    Ullman B; Gudas LJ; Clift SM; Martin DW
    Proc Natl Acad Sci U S A; 1979 Mar; 76(3):1074-8. PubMed ID: 108675
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enzyme defects and immune dysfunction.
    Rosen FS
    Nature; 1978 Dec; 276(5688):559-60. PubMed ID: 102999
    [No Abstract]   [Full Text] [Related]  

  • 5. Deoxyguanosine toxicity on lymphoid cells as a cause for immunosuppression in purine nucleoside phosphorylase deficiency.
    Chan TS
    Cell; 1978 Jul; 14(3):523-30. PubMed ID: 99242
    [No Abstract]   [Full Text] [Related]  

  • 6. Phosphorylation of deoxyguanosine by B and T lymphocytes: evidence against selective trapping of deoxyguanosine by T lymphocytes in purine nucleoside phosphorylase deficiency.
    North ME; Newton CA; Webster AD
    Clin Exp Immunol; 1980 Dec; 42(3):523-9. PubMed ID: 6783354
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The metabolism of deoxyguanosine and guanosine in human B and T lymphoblasts. A role for deoxyguanosine kinase activity in the selective T-cell defect associated with purine nucleoside phosphorylase deficiency.
    Osborne WR; Scott CR
    Biochem J; 1983 Sep; 214(3):711-8. PubMed ID: 6312962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency.
    Cohen A; Gudas LJ; Ammann AJ; Staal GE; Martin DW
    J Clin Invest; 1978 May; 61(5):1405-9. PubMed ID: 96138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary purines in a patient with a severely defective T cell immunity and a purine nucleoside phosphorylase deficiency.
    Wadman SK; de Bree PK; van Gennip AH; Stoop JW; Zegers BJ; Staal GE; Siegenbeek LH
    Adv Exp Med Biol; 1977; 76A():471-6. PubMed ID: 404853
    [No Abstract]   [Full Text] [Related]  

  • 10. [Primary immunodeficiencies and purine metabolism].
    Romo Cortina A; Lorente Toledano F; Salazar Villalobos V
    Rev Clin Esp; 1985 Oct; 177(6):247-53. PubMed ID: 3001848
    [No Abstract]   [Full Text] [Related]  

  • 11. Purine nucleoside phosphorylase deficiency: a molecular model for selective loss of T cell function.
    Ochs UH; Chen SH; Ochs HD; Osborne WR; Scott CR
    J Immunol; 1979 Jun; 122(6):2424-9. PubMed ID: 109531
    [No Abstract]   [Full Text] [Related]  

  • 12. The mechanism of inhibition and "reversal" of mitogen-induced lymphocyte activation in a model of purine-nucleoside phosphorylase deficiency.
    Albert D; Bluestein HG; Willis RC; Nette K; Seegmiller JE
    Cell Immunol; 1984 Jul; 86(2):501-9. PubMed ID: 6428752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partial deficiency of purine nucleoside phosphorylase: studies of purine and pyrimidine metabolism.
    Edwards NL; Gelfand EW; Biggar D; Fox IH
    J Lab Clin Med; 1978 May; 91(5):736-49. PubMed ID: 417142
    [No Abstract]   [Full Text] [Related]  

  • 14. A rat model of purine nucleoside phosphorylase deficiency.
    Osborne WR; Barton RW
    Immunology; 1986 Sep; 59(1):63-7. PubMed ID: 3019875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible metabolic basis for the different immunodeficient states associated with genetic deficiencies of adenosine deaminase and purine nucleoside phosphorylase.
    Carson DA; Wasson DB; Lakow E; Kamatani N
    Proc Natl Acad Sci U S A; 1982 Jun; 79(12):3848-52. PubMed ID: 6808516
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide metabolism in cultured T cells and in cells of patients deficient in adenosine deaminase and purine nucleoside phosphorylase.
    Cohen A; Gudas LJ; Ullman B; Martin DW
    Ciba Found Symp; 1978; (68):101-14. PubMed ID: 115659
    [No Abstract]   [Full Text] [Related]  

  • 17. Deoxyribonucleoside toxicity in adenosine deaminase and purine nucleoside phosphorylase deficiency: implications for the development of new immunosuppressive agents.
    Carson DA; Kaye J
    Ciba Found Symp; 1978; (68):115-33. PubMed ID: 115660
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purine nucleoside phosphorylase deficiency associated with a fatal lymphoproliferative disorder.
    Watson AR; Evans DI; Marsden HB; Miller V; Rogers PA
    Arch Dis Child; 1981 Jul; 56(7):563-5. PubMed ID: 6791594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biochemistry of diseases of immunodevelopment.
    Martin DW; Gelfand EW
    Annu Rev Biochem; 1981; 50():845-77. PubMed ID: 6267992
    [No Abstract]   [Full Text] [Related]  

  • 20. Lymphospecific toxicity in adenosine deaminase deficiency and purine nucleoside phosphorylase deficiency: possible role of nucleoside kinase(s).
    Carson DA; Kaye J; Seegmiller JE
    Proc Natl Acad Sci U S A; 1977 Dec; 74(12):5677-81. PubMed ID: 202960
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.